درباره این اپیزود
95% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes.
The CDMO model is evolving fast, but what actually separates the leaders from the rest in today’s market?
This week on Making It In Manufacturing, Harry Sloan sat down with Thierry Van Nieuwenhove, CEO of Quotient Sciences, with 25+ years of experience spanning business development, engineering, global manufacturing leadership, and executive roles.
In this episode, Thierry covers:
• The evolution of the CDMO landscape over 25 years, from API-focused events to a global, multi-disciplinary pharma ecosystem
• How Quotient Sciences built a unique translational pharmaceutics platform to combine clinical studies with drug manufacturing, accelerating development timelines by up to 12 months
• A career journey from chemical engineering into global business development and leadership, including building manufacturing capabilities in India and working across Europe and the US
• Why speed, efficiency, and proof of concept are critical in today’s funding-constrained biotech environment
• The growing impact of AI, global innovation shifts including China, and how CDMOs must adapt to remain competitive and support emerging biotech pipelines
If you are looking to understand where the CDMO space is heading, and what it takes to lead in a rapidly evolving pharmaceutical market, this episode offers a clear and practical perspective. Be sure to watch the full conversation.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com/
Youtube: https://www.youtube.com/@life_sciences
Thierry Van Nieuwenhove
CEO at Quotient Sciences
LinkedIn: https://www.linkedin.com/in/thierryvan/
Harry Sloan
BD CDMO Lead
LinkedIn: https://www.linkedin.com/in/harry-sloan-605620154/
Timestamps:
00:00 Introduction to Making It In Manufacturing at DCAT
00:20 Meet Thierry Van Nieuwenhove, CEO of Quotient Sciences
01:40 Overview of Quotient Sciences and translational pharmaceutics
03:10 Competitive advantage in the CDMO market
04:23 Career journey from engineering to CEO
07:00 Leadership development across global roles
08:18 Operating across international markets and cultures
09:17 Translating early-stage assets into clinical success
12:00 Industry challenges including funding constraints
14:25 AI, partnerships, and innovation in formulation
16:01 Data science and accelerating development timelines
17:32 Global trends including China’s role in innovation
19:56 Strategic adaptation to industry shifts
21:34 Demand for integrated CDMO models
22:55 Customer expectations: speed, excellence, and innovation
25:28 The importance of trust and long-term partnerships
#MakingItInManufacturing #ARTOTalent #CDMO #PharmaceuticalManufacturing #Biotech #DrugDevelopment #LifeSciences
Hosted on Acast. See acast.com/privacy for more information.
